Legal Opinion
In re Lipitor (Atorvastatin Calcium) Marketing, Sales Practices & Products Liability Litigation
District Court, D. South Carolina
Decided March 30, 2016No. MDL No. 2:14-mn-02502-RMGPublishedCited by 16 opinions
1Opinion of the Court
*913CASE MANAGEMENT ORDER NO. 68
This Order relates to all cases.
Richard Mark Gergel, United States District Court Judge
This matter is before the Court on Pfizer’s Motion to Exclude Plaintiffs’ Expert *914Testimony on the Issue of General Causation. (Dkt. No. 972). For the reasons stated below, the motion is GRANTED IN PART AND DENIED IN PART.
I. Background
In this MDL, Plaintiffs allege that Lipitor caused their Type 2 diabetes. “[I]n order to carry the burden of proving a plaintiffs injury was caused by exposure to a specified substance,” a plaintiff must demonstrate general and specific causation.…
2Cases cited38 opinions
- Daubert v. Merrell Dow Pharmaceuticals, Inc.Supreme Court of the United States · 1993
- Kumho Tire Co. v. CarmichaelSupreme Court of the United States · 1999
- General Electric Co. v. JoinerSupreme Court of the United States · 1997
- Westberry v. Gislaved Gummi ABCourt of Appeals for the Fourth Circuit · 1999
- United States v. ValenciaCourt of Appeals for the Fifth Circuit · 2010
33 more not listed; retrieve them via the Exa API.
3Cited by16 opinions
- Lipitor (Atorvastatin Calcium) Mktg. v. Pfizer, Inc.Court of Appeals for the Fourth Circuit · 2018
- In re Onglyza (Saxagliptin) and Kombiglyze (Saxagliptin and Metformin) Prods. Liability Litig.Court of Appeals for the Sixth Circuit · 2024
- In re Mirena Ius Levonorgestrel-Related Prods. Liab. Litig.District Court, S.D. Illinois · 2018
- In re Abilify (Aripiprazole) Prods. Liab. Litig.District Court, N.D. Florida · 2018
- In re Lipitor (Atorvastatin Calcium) Marketing, Sales Practices & Products Liability LitigationDistrict Court, D. South Carolina · 2017
11 more not listed; retrieve them via the Exa API.